Biopharma Business

Laboratory

New Precision Medicine Centre of Excellence Will Improve Patient Treatment

    New Precision Medicine Centre of Excellence Will Improve Patient Treatment

A £10 million Centre of Excellence in Precision Medicine has been launched by Invest Northern Ireland and Queen’s University Belfast. The Centre of Excellence in Precision Medicine will develop an

Read Full Article

EMA to Evaluate Liver Problems Linked to Zinbryta

    EMA to Evaluate Liver Problems Linked to Zinbryta

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) discussed the safety reviews of a variety of medications during its June 2017 meeting. The medicines in review included treatments for

Read Full Article

Ingestible balloon could help reduce obesity

    Ingestible balloon could help reduce obesity

A new study has shown that an ingestible gastric balloon could be used to help obese people lose weight without the need for invasive surgery. When swallowed the Elipse balloon

Read Full Article

The continuum of HIV care: What does it mean and how is Europe doing?

    The continuum of HIV care: What does it mean and how is Europe doing?

From diagnosis of HIV to successful viral suppression: this new ECDC report summarises key findings concerning and the Continuum of HIV Care in Europe based on data reported by countries

Read Full Article

Promising Preclinical Results of Zika Virus Vaccine

    Promising Preclinical Results of Zika Virus Vaccine

  Preclinical results of research by City College of New York scientists and TechnoVax, Inc. in animal models demonstrate favorable outcomes in developing a vaccine against the mosquito-borne Zika virus.

Read Full Article

HIV Treatment Development Extends Life Expectancy by 10 Years

    HIV Treatment Development Extends Life Expectancy by 10 Years

According to a new study, the life expectancy of 20-year-olds starting HIV treatment has increased by a decade in the EU and North America. A massive new study from the

Read Full Article

French Biotech Could Be Taking its Diabetes Drug to Phase III on its own

Poxel was able to score positive results for its type 2 diabetes drug in a Phase IIb study in Japan, preparing the company to go for a Phase III program. Poxel, one of

Read Full Article

Fungi have enormous potential for new antibiotics

Fungi are a potential goldmine for the production of pharmaceuticals. This is shown by researchers at Chalmers University of Technology, who have developed a method for finding new antibiotics from

Read Full Article

First patient recruited in Phase Ib trial of TG02

The first patient has been recruited in an exploratory Phase Ib clinical trial of Targovax’s second product from its RAS-peptide immunotherapy platform, TG02. In the open-label, non-randomised trial — to

Read Full Article

Allergan and Novartis Collaborate on Multi-Therapy Treatment for NASH

Allergan, a global biopharmaceutical company, announced that it has entered into a clinical trial agreement with Novartis to conduct a Phase 2b study, using Allergan’s cenicriviroc (CVC) and Novartis’ lead FXR

Read Full Article

Swiss-Danish Collaboration will use Synbio to Produce a B Vitamin

Two startups in the fields of synthetic biology, Biosyntia and FGen, have struck a partnership to identify promising microbial strains. The objective is to find a strain that enables bioproduction

Read Full Article

Data Supports Advancement of Botox as Depression Treatment

Allergan plc, a global pharmaceutical company announced topline data from a phase II study with major depressive disorder (MDD). The study evaluated the efficacy, safety and tolerability of a single administration

Read Full Article

Novartis’ lung cancer drug combination receives EU approval

The European Commission has approved Novartis’ Tafinlar (dabrafenib) in combination with Mekinist (trametinib) for the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer (NSCLC). The

Read Full Article

Anti-cancer drug gets a boost when combined with antirheumatic

Scientists at EPFL and NTU have discovered that combining an anticancer drug with an antirheumatic produces improved effects against tumors. The discovery opens a new path for drug-drug synergy. One

Read Full Article

EMA Suspends Drugs Associated with Micro Therapeutic Research Labs

The agency is recommending the suspension of a variety of medications because of unreliable bioequivalence studies conducted by Micro Therapeutic Research Labs The European Medicines Agency (EMA) announced on March

Read Full Article

Novartis puts the Development of two Anti-Aging Drugs in American Hands

PureTech will take on the development of two mTORC1 inhibitors from Novartis aimed at stopping the decline of the immune system associated with age. Novartis is building up the portfolio

Read Full Article

Alzheimer’s disease linked to the metabolism of unsaturated fats

  A new study published in PLOS Medicine’s Special Issue on Dementia has found that the metabolism of omega-3 and omega-6 unsaturated fatty acids in the brain are associated with

Read Full Article

Dublin researchers discover way to prevent infections on medical devices

Researchers at Trinity College Dublin have discovered a way to prevent bacteria from growing on medical devices that are implanted in the human body.  The researchers state the discovery is

Read Full Article

A New Parkinson’s Drug from Italy just got FDA Approval!

Newron, an Italian biotech focused on CNS diseases, is on a roll. The latest win? FDA approval of its Parkinson’s drug, Xadago. Just in time for World Parkinson’s Day on

Read Full Article

Shire’s HAE drug Cinryze secures label extension in Europe

Shire has secured label expansion approval from the European Commission for its hereditary angioedema therapy Cinryze. The European Commission (EC) has approved the label extension application, granting three new indications

Read Full Article

French Biotech fails Second Phase II Trial for Cardiovascular Disease

Cerenis therapeutic’s lead candidate CER-001 has failed Phase II for the treatment of patients with post-acute coronary syndrome (ACS). The French-based Biotech Cerenis is developing therapies for the treatment ofcardiovascular and

Read Full Article

British Biotech’s Breast Cancer Drug gets FDA Approval for Novartis

Novartis has received FDA approval for Kisqali, a first-line treatment for breast cancer originally developed by the British biotech Astex Pharmaceuticals. The oncology company Astex Pharmaceuticals, located in Cambridge’s biotech hub, entered

Read Full Article

The First 3D Structure of Active DNA could advance Stem Cell Therapies

Scientists from the University of Cambridge have determined the first 3D structures of mammalian genomes from individual cells. For the

Read Full Article

MedImmune and Sanofi Pasteur form alliance to develop and commercialise potential next-generation respiratory syncytial virus antibody MEDI8897

MedImmune, the global biologics research and development arm of AstraZeneca, and Sanofi Pasteur, the vaccines division of Sanofi, have announced

Read Full Article

EU Grants Orphan Drug Designation for Epidermolysis Bullosa Treatment

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing gene therapies for life-threatening rare diseases, announced today that the

Read Full Article

Italy Adopts Gender-Neutral HPV Vaccination Program

Italy adopts gender-neutral HPV vaccination program, citing study by health economics expert from Kingston University London’s Business School. The Italian

Read Full Article

Medical device helps doctors and nurses take blood

Medical device company Olberon has developed a product to help doctors and nurses insert needles into patients’ blood. Olberon states

Read Full Article

Merck and Pfizer’s diabetes therapy under US, EU review

Regulators on both sides of the Atlantic are reviewing three new submissions for medicines containing ertugliflozin, an investigational SGLT2 inhibitor

Read Full Article

Actelion gets EU Approval to Launch a Treatment for a Rare Skin Cancer

Actelion has received approval from the European Commission for Ledaga, a treatment to prevent the progression of a rare form

Read Full Article

New research to help detect oesophageal cancer earlier

A new method to help diagnose oesophageal cancer is being researched by engineers and physicians at the Institute of Biological

Read Full Article

Owlstone Medical to provide breath biomarker services for 4D Pharma

Diagnostics company, Owlstone Medical, who is developing a breathalyser for disease has announced it has signed a master service agreement

Read Full Article

Scottish universities link to develop stem cell therapies

Researchers at the Universities of Dundee and Edinburgh in Scotland are looking to work with the pharmaceutical industry to improve

Read Full Article

Sanofi and AstraZeneca to Collaborate on Antibody for Prevention of Respiratory Illnesses

Sanofi and its vaccines global business unit Sanofi Pasteur announced today an agreement with MedImmune, the global biologics research and development arm of

Read Full Article

Gene Therapy Lets a French Teen Dodge Sickle Cell Disease

A French teen who was given gene therapy for sickle cell disease more than two years ago now has enough

Read Full Article

European Reference Networks: 900 medical teams to connect across Europe for the benefit of patients

On 1 March the newly established European Reference Networks (ERNs) has started their work. ERNs are unique and innovative cross-border

Read Full Article

DIA EuroMeeting explores the road ahead for drug development in the EU and UK

29 – 31 March 2017, Glasgow, United Kingdom. DIA, (founded as the Drug Information Association) announced critical workshops to be

Read Full Article

The Dirty Dozen: UN Issues List of 12 Most Worrying Bacteria

The World Health Organization has issued a list of the top dozen bacteria most dangerous to humans, warning that doctors

Read Full Article

CHTS & Biopharma Group join forces in Ireland

The Irish division of Crowthorne Hi-Tec Services (CHTS) has joined forces with Biopharma Group to offer combined services throughout the whole

Read Full Article

Sanofi and Lonza announce partnership to develop biologics facility

The joint venture will combine Sanofi’s biologics development pipeline with Lonza’s expertise to design, construct, start-up and operate a state-of-the-art

Read Full Article

EMA Recommends Six Medicines for Market Approval

On Feb. 24, 2017, the European Medicines Agency (EMA) announced that its Committee for Medicinal Products for Human Use (CHMP) recommended six

Read Full Article

FDA’s Office of Generic Drugs Releases Annual Report

FDA’s Office of Generic Drugs (OGD) released their 2016 Annual Report on Feb. 24, 2017. The report details the office’s accomplishments

Read Full Article

Orphan Drug Natpar Receives EMA Recommendation

The European Medicines Agency (EMA) announced on Feb. 24, 2017 that its Committee for Medicinal Products for Human Use (CHMP) has

Read Full Article

GSK Reports Positive Results for Once-Daily Inhaled Corticosteroid

GlaxoSmithKline plc and Innoviva, Inc. announced positive headline results from a non-inferiority lung function study, which demonstrated that patients with well-controlled asthma were

Read Full Article

Innovation for Health launched by University of Surrey

The University of Surrey has launched a new academic programme, aimed to help change the delivery of healthcare in the

Read Full Article

ACIB and GE Healthcare establish cell line engineering collab

The Austrian Centre of Industrial Biotechnology (acib) and GE Healthcare are introducing a cell line engineering research collaboration to bring

Read Full Article

European Commission conditionally approves Roche’s cancer drug Alecensa

Roche’s oral ALK inhibitor, Alecensa, has been conditionally approved in the European Union as a monotherapy for anaplastic lymphoma kinase-positive

Read Full Article

Dutch and German Biotechs enter the Clinic with their First Lanthipeptide

Lanthio Pharma has initiated a Phase I clinical trial with its lanthipeptide candidate MOR107, which is being developed as a

Read Full Article

Emory scientists map ‘spiderweb’ of lung cancer proteins to snare new drug targets

Scientists at Emory University’s Winship Cancer Institute are on a mission to unlock the mysteries of lung cancer cells that

Read Full Article

DNA computer brings ‘intelligent drugs’ a step closer

Researchers at Eindhoven University of Technology (TU/e) present a new method that should enable controlled drug delivery into the bloodstream

Read Full Article

Cambridge Research Biochemicals announces new antibodies catalogue

Cambridge Research Biochemicals (CRB), specialist in the synthesis of custom peptides and antibody production has announced the release of its new

Read Full Article

Faron Pharmaceuticals recruits first patient for new Traumakine trial

Faron Pharmaceuticals has recruited its first patient to a phase II clinical trial of its lead drug, Traumakine, in the

Read Full Article

Mereo’s brittle bone drug joins EU’s adaptive pathways scheme

UK-based rare and speciality diseases group Mereo BioPharma says its brittle bone disease drug BPS-804 has been accepted to participate

Read Full Article

Sterile Manufacturing Deviations Found at Japan Facility

On Feb. 2, 2017, FDA issued a warning letter to Sato Pharmaceutical Co., Ltd. after inspectors found current good manufacturing

Read Full Article

Swedish Fundraising brings Sickle Cell Disease Drug Closer to the Market

Modus Therapeutics has raised €3.4M to support the completion of a Phase II trial for sickle cell disease, a painful condition

Read Full Article

Upcoming Events

  • November 12, 2018Compamed
  • November 13, 2018Foodpharmatech
  • April 21, 2019Labvolution
AEC v1.0.4

The Magazine

New Subscriber





Subscribe Here



Advertisements